About

Name

Glen Baker
University

University of Alberta
Website

psychiatry.med.ualberta.ca/AboutUs/DepartmentMembers/Academic/Baker.aspx
Email

[email protected]
Research Keywords

biomarkers in psychiatric and neurological disorders, neurochemistry of depression, schizophrenia and anxiety disorders, drug metabolism and drug interactions, neuroprotective drugs

Additional Information

Lab Methodologies
  • Neurosteroid Assays
  • Amino acid detection
  • Biogenic amines and metabolites including trace amines
  • Radiochemical lab
Apparatus
  • HPLC (fluorimetry, electrochemical, UV detection)
  • HPLC Mass Spectrometry
  • Gas Chromatography Electron Capture detector
  • Gas Chromatography Mass Spectrometry including Triple Quad
  • Liquid Scintillation Counter

 

Roles and Connections

Primary Role

Faculty
CAN Connections

Depression

Most Cited Publications

Casey KF, Benkelfat C, Cherkasova MV, Baker GB, Dagher A, Leyton M, "Reduced dopamine response to amphetamine in subjects at ultra-high risk for addiction." Biological psychiatry 76,1 (2014 Jul 1): 23-30
Vivithanaporn P, Asahchop EL, Acharjee S, Baker GB, Power C, "HIV protease inhibitors disrupt astrocytic glutamate transporter function and neurobehavioral performance." AIDS (London, England) 30,4 (2016 Feb 20): 543-52
Chrapko W, Jurasz P, Radomski MW, Archer SL, Newman SC, Baker G, Lara N, Le Mellédo JM, "Alteration of decreased plasma NO metabolites and platelet NO synthase activity by paroxetine in depressed patients." Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 31,6 (2006 Jun): 1286-93